The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications

被引：0
|
作者：
Steffen M. Heckl
Viva Wiesener
Hans-Michael Behrens
Dita Ulase
Sandra Krüger
Christoph Röcken
机构：
[1] Christian-Albrechts-University,Department of Pathology
[2] University Hospital Schleswig–Holstein,Department of Internal Medicine I
[3] Riga Stradins University,Department of Pathology
来源：
Gastric Cancer | 2019年 / 22卷
关键词：
Gastric cancer; Insulin receptor; HER-2 Proto-Oncogene Protein; Prognosis; Cancer treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1130 / 1142
页数：12
相关论文
共 50 条
  • [31] HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
    Gravalos, C.
    Jimeno, A.
    ANNALS OF ONCOLOGY, 2008, 19 (09) : 1523 - 1529
  • [32] Over-expression of HER2 in Indian patients with gastric cancer
    Prachi S. Patil
    Shaesta A. Mehta
    K. M. Mohandas
    Indian Journal of Gastroenterology, 2013, 32 (5) : 350 - 350
  • [33] Clinicopathological Features and Prognostic Significance of HER2 Expression in Gastric Cancer
    Park, Ji Soo
    Rha, Sun Young
    Chung, Hyun Cheol
    Jung, Minkyu
    Kim, Ki Hyang
    Jun, Hyun Jung
    Kim, Hyunki
    An, Ji Yeong
    Kim, Hyoung-Il
    Cheong, Jae-Ho
    Hyung, Woo Jin
    Noh, Sung Hoon
    Kim, Hyo Song
    ONCOLOGY, 2015, 88 (03) : 147 - 156
  • [34] Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment
    Shitara, Kohei
    Yatabe, Yasushi
    Matsuo, Keitaro
    Sugano, Masato
    Kondo, Chihiro
    Takahari, Daisuke
    Ura, Takashi
    Tajika, Masahiro
    Ito, Seiji
    Muro, Kei
    GASTRIC CANCER, 2013, 16 (02) : 261 - 267
  • [35] Comparison of HER2 status by fluorescence in situ hybridisation and immunohistochemistry in gastric cancer
    Ming Chen
    Yan Li
    Zhou Ming
    Ai Biao
    Liu Xue Zheng
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2014, 18 (02): : 95 - 99
  • [36] Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment
    Kohei Shitara
    Yasushi Yatabe
    Keitaro Matsuo
    Masato Sugano
    Chihiro Kondo
    Daisuke Takahari
    Takashi Ura
    Masahiro Tajika
    Seiji Ito
    Kei Muro
    Gastric Cancer, 2013, 16 : 261 - 267
  • [37] Serum HER2 Is a Potential Surrogate for Tissue HER2 Status in Gastric Cancer: A Systematic Review and Meta-Analysis
    Zhang, Kecheng
    Cui, Jianxin
    Xi, Hongqing
    Bian, Shibo
    Ma, Liangang
    Shen, Weisong
    Li, Jiyang
    Wang, Ning
    Wei, Bo
    Chen, Lin
    PLOS ONE, 2015, 10 (08):
  • [38] HER2 Status in Colorectal Cancer: Its Clinical Significance and the Relationship between HER2 Gene Amplification and Expression
    Seo, An Na
    Kwak, Yoonjin
    Kim, Duck-Woo
    Kang, Sung-Bum
    Choe, Gheeyoung
    Kim, Woo Ho
    Lee, Hye Seung
    PLOS ONE, 2014, 9 (05):
  • [39] Somatostatin Receptor Subtype 2 A (SSTR2A) and HER2 Expression in Gastric Adenocarcinoma
    Romiti, Adriana
    Di Rocco, Roberta
    Milione, Massimo
    Ruco, Luigi
    Ziparo, Vincenzo
    Zullo, Angelo
    Duranti, Enrico
    Sarcina, Ida
    Barucca, Viola
    D'Antonio, Chiara
    Marchetti, Paolo
    ANTICANCER RESEARCH, 2012, 32 (01) : 115 - 119
  • [40] Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients
    Qiu, Miaozhen
    Zhou, Yixin
    Zhang, Xinke
    Wang, Zixian
    Wang, Fang
    Shao, Jianyong
    Lu, Jiabin
    Jin, Ying
    Wei, Xiaoli
    Zhang, Dongsheng
    Wang, Fenghua
    Li, Yuhong
    Yang, Dajun
    Xu, Ruihua
    BMC CANCER, 2014, 14
12345